Related Experiment Video
Updated: May 18, 2026
09:50
Real-time Quaking-induced Conversion Assay for Detection of CWD Prions in Fecal Material
Published on: September 29, 2017
Characterization of conformation-dependent prion protein epitopes
Hae-Eun Kang1, Chu Chun Weng, Eri Saijo
1Prion Research Center, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado 80523, USA.
The Journal of Biological Chemistry
|September 6, 2012
Summary
This study identifies specific amino acids in prion protein (PrP) that form conformational epitopes, crucial for understanding prion diseases. These findings clarify how antibodies detect pathogenic PrP forms.
Area of Science:
- Neuroscience
- Biochemistry
- Immunology
Background:
- Prion replication involves structural changes in cellular prion protein (PrP(C)).
- Conformational epitopes of PrP are poorly understood and debated.
- PrP transformation is typically monitored using protease-resistant PrP (PrP(27-30)).
Purpose of the Study:
- To identify specific amino acids involved in conformational epitopes of PrP.
- To characterize novel monoclonal antibodies (mAbs) targeting these epitopes.
- To investigate the structural basis of PrP recognition by mAbs.
Main Methods:
- Generation of randomly chimeric PrP constructs.
- Development and characterization of novel monoclonal antibodies (mAbs).
- Epitope mapping using amino acid polymorphisms and structural perturbation studies.
Main Results:
- Two novel mAbs, PRC5 and PRC7, recognized discontinuous epitopes within the PrP globular domain.
- PRC5 recognition depended on alanine at residue 132 and asparagine at 158.
- PRC7 recognition was glycosylation-dependent and mapped to residues 154 and 185.
- Tertiary structure changes disrupted recognition by conformation-dependent mAbs, but not others.
- Both cellular PrP and PrP(27-30) renature to a common structure.
Conclusions:
- Specific amino acids within the PrP globular domain are critical for conformational epitope recognition.
- Monoclonal antibodies can distinguish between PrP conformers based on these structural determinants.
- Understanding these epitopes is key to developing diagnostic tools for prion diseases.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
02:50Conjugated Proteins
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...